Chemed names Michael Witzeman CFO effective January 1, 2024, succeeding David Williams
Chemed's board appointed Michael D. Witzeman, the company's Vice President and Controller, as Chief Financial Officer effective January 1, 2024. The change follows the retirement of David P. Williams from the CFO role, and Witzeman will also continue as Controller and Vice President.
- Michael D. Witzeman appointed CFO by the board on December 18, 2023, effective January 1, 2024
- Replaces David P. Williams, who is retiring from the CFO role
- Witzeman joined Chemed in 2005 after Deloitte & Touche LLP and is a licensed CPA
- Witzeman will keep his Controller and Vice President roles